Equity Profile

LQDA

Liquidia Corporation

Health CarePharmaceuticals$6.3B

May11Mon

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:30 AM EDT

Liquidia Corporation Beats on EPS, Stock Down 0.02%

Metric	Actual	Expected	Surprise
EPS	$0.52	$0.41	+54.76%
Revenue	—	$117M	—

management commentary, guidance changes, and full analysis available with Pro.

Liquidia Corporation Beats on EPS, Stock Down 0.02%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.52	$0.41	+54.76%
Revenue	—	$117M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Liquidia Corporation reported better-than-expected earnings per share, which is a positive indicator for the company's profitability. However, the stock saw a slight decline of 0.02%, suggesting that investors may have been expecting more clarity or additional information that was not provided in this report. The lack of revenue figures and guidance may have contributed to the muted stock reaction.

Company Snapshot

Liquidia Corporation is a pharmaceutical company focused on developing innovative treatments for patients with serious diseases. With a market cap of $4 billion, it operates in the health care sector, addressing significant medical needs through its proprietary technologies.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$0.41

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$117M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+21.08%

Avg Stock Reaction

+4.49%

Last Quarter Recap

In the last quarter, Liquidia reported an EPS of $0.15, significantly beating estimates of $0.07. The stock reacted positively, gaining 0.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Liquidia's upcoming earnings, expecting a solid EPS and revenue performance. The company has shown a capacity for surprising the market positively in recent quarters.

Bull Case

If Liquidia meets or exceeds the consensus estimates, it could signal strong demand for its products and effective cost management, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth prospects and market position, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.41

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$117M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Liquidia's EPS exceed the consensus estimate of $0.41?

A beat on EPS could reinforce investor confidence and drive the stock price up, while a miss could lead to negative sentiment.

What is the revenue figure compared to the expected $117 million?

Revenue performance is critical for assessing the company's market demand and growth trajectory, impacting future forecasts.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Liquidia's ability to capitalize on recent product developments, which could lead to higher-than-expected revenue.

Supporting Evidence

Liquidia has a history of surprising the market positively, as seen in recent quarters.

The options market is pricing in a larger move than historical averages suggest, indicating potential for a significant reaction.

Key Risk

If revenue comes in below $97 million, it could undermine the optimistic projections for the company's growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating Liquidia's ability to sustain profitability and revenue growth in a competitive pharmaceutical landscape.

Bull Confirmed If

Earnings per share of $0.41 or higher would confirm the bullish outlook.

Bear Confirmed If

Earnings per share below $0.33 would support the bearish case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.35%

Historical Avg

±6.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±14.4% while LQDA has averaged ±6.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.3%

30d HV

46.1%

Calls (381K)P/C Ratio: 0.16Puts (60K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Liquidia beats expectations, history suggests a positive stock reaction, potentially gaining around +0.18% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average drop of around +2.68% on such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market demand and competitive positioning.
3Insights into cost management strategies and their impact on profitability.
4Guidance on future revenue expectations and growth targets.
5Responses to analyst questions regarding recent insider selling activity.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May8

AQNReported

Algonquin Power & Utilities Corp.

RecapView

May8

ESNTReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$0.41

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$117M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+21.08%

Avg Stock Reaction

+4.49%

Last Quarter Recap

In the last quarter, Liquidia reported an EPS of $0.15, significantly beating estimates of $0.07. The stock reacted positively, gaining 0.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Liquidia meets or exceeds the consensus estimates, it could signal strong demand for its products and effective cost management, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth prospects and market position, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.41

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$117M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Liquidia's EPS exceed the consensus estimate of $0.41?

A beat on EPS could reinforce investor confidence and drive the stock price up, while a miss could lead to negative sentiment.

What is the revenue figure compared to the expected $117 million?

Revenue performance is critical for assessing the company's market demand and growth trajectory, impacting future forecasts.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Liquidia's ability to capitalize on recent product developments, which could lead to higher-than-expected revenue.

Supporting Evidence

Liquidia has a history of surprising the market positively, as seen in recent quarters.

The options market is pricing in a larger move than historical averages suggest, indicating potential for a significant reaction.

Key Risk

If revenue comes in below $97 million, it could undermine the optimistic projections for the company's growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating Liquidia's ability to sustain profitability and revenue growth in a competitive pharmaceutical landscape.

Bull Confirmed If

Earnings per share of $0.41 or higher would confirm the bullish outlook.

Bear Confirmed If

Earnings per share below $0.33 would support the bearish case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.35%

Historical Avg

±6.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±14.4% while LQDA has averaged ±6.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.3%

30d HV

46.1%

Calls (381K)P/C Ratio: 0.16Puts (60K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Liquidia beats expectations, history suggests a positive stock reaction, potentially gaining around +0.18% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average drop of around +2.68% on such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market demand and competitive positioning.
3Insights into cost management strategies and their impact on profitability.
4Guidance on future revenue expectations and growth targets.
5Responses to analyst questions regarding recent insider selling activity.